Synexus Manchester Clinical Research Centre

Manchester, Greater Manchester M15 6SX

1 studies enrolling now · 6 studies all time

What they study most

Crohn's Disease, Dyslipidemia, Hyperlipidemia, Migraine, Migraine Disorders, Transthyretin Amyloid Cardiomyopathy (ATTR CM), Type2 Diabetes

Studies at this site

• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis — Recruiting now
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed